314 related articles for article (PubMed ID: 22559663)
1. Dose calculation for photon-emitting brachytherapy sources with average energy higher than 50 keV: report of the AAPM and ESTRO.
Perez-Calatayud J; Ballester F; Das RK; Dewerd LA; Ibbott GS; Meigooni AS; Ouhib Z; Rivard MJ; Sloboda RS; Williamson JF
Med Phys; 2012 May; 39(5):2904-29. PubMed ID: 22559663
[TBL] [Abstract][Full Text] [Related]
2. Supplement 2 for the 2004 update of the AAPM Task Group No. 43 Report: Joint recommendations by the AAPM and GEC-ESTRO.
Rivard MJ; Ballester F; Butler WM; DeWerd LA; Ibbott GS; Meigooni AS; Melhus CS; Mitch MG; Nath R; Papagiannis P
Med Phys; 2017 Sep; 44(9):e297-e338. PubMed ID: 28644913
[TBL] [Abstract][Full Text] [Related]
3. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
[TBL] [Abstract][Full Text] [Related]
4. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
Ho Than MT; Munro Iii JJ; Medich DC
J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric characterization of an 192Ir brachytherapy source with the Monte Carlo code PENELOPE.
Casado FJ; García-Pareja S; Cenizo E; Mateo B; Bodineau C; Galán P
Phys Med; 2010; 26(3):132-9. PubMed ID: 20034828
[TBL] [Abstract][Full Text] [Related]
7. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric characterization of the GammaClip™ 169Yb low dose rate permanent implant brachytherapy source for the treatment of nonsmall cell lung cancer postwedge resection.
Currier B; Munro JJ; Medich DC
Med Phys; 2013 Aug; 40(8):080701. PubMed ID: 23927294
[TBL] [Abstract][Full Text] [Related]
9. A dosimetric uncertainty analysis for photon-emitting brachytherapy sources: report of AAPM Task Group No. 138 and GEC-ESTRO.
DeWerd LA; Ibbott GS; Meigooni AS; Mitch MG; Rivard MJ; Stump KE; Thomadsen BR; Venselaar JL
Med Phys; 2011 Feb; 38(2):782-801. PubMed ID: 21452716
[TBL] [Abstract][Full Text] [Related]
10. Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources.
Melhus CS; Rivard MJ
Med Phys; 2006 Jun; 33(6):1729-37. PubMed ID: 16872080
[TBL] [Abstract][Full Text] [Related]
11. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
Aryal P; Molloy JA; Rivard MJ
Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
[TBL] [Abstract][Full Text] [Related]
12. RapidBrachyTG43: A Geant4-based TG-43 parameter and dose calculation module for brachytherapy dosimetry.
Kalinowski J; Enger SA
Med Phys; 2024 May; 51(5):3746-3757. PubMed ID: 38252746
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric prerequisites for routine clinical use of photon emitting brachytherapy sources with average energy higher than 50 kev.
Li Z; Das RK; DeWerd LA; Ibbott GS; Meigooni AS; Pérez-Calatayud J; Rivard MJ; Sloboda RS; Williamson JF; ;
Med Phys; 2007 Jan; 34(1):37-40. PubMed ID: 17278487
[TBL] [Abstract][Full Text] [Related]
14. Recommendations of the American Association of Physicists in Medicine regarding the impact of implementing the 2004 task group 43 report on dose specification for 103Pd and 125I interstitial brachytherapy.
Williamson JF; Butler W; Dewerd LA; Huq MS; Ibbott GS; Mitch MG; Nath R; Rivard MJ; Todor D;
Med Phys; 2005 May; 32(5):1424-39. PubMed ID: 15984693
[TBL] [Abstract][Full Text] [Related]
15. Supplement to the 2004 update of the AAPM Task Group No. 43 Report.
Rivard MJ; Butler WM; DeWerd LA; Huq MS; Ibbott GS; Meigooni AS; Melhus CS; Mitch MG; Nath R; Williamson JF;
Med Phys; 2007 Jun; 34(6):2187-205. PubMed ID: 17654921
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of TG-43 recommended 2D-anisotropy function for elongated brachytherapy sources.
Awan SB; Meigooni AS; Mokhberiosgouei R; Hussain M
Med Phys; 2006 Nov; 33(11):4271-9. PubMed ID: 17153405
[TBL] [Abstract][Full Text] [Related]
17. Monte Carlo Dosimetry of the 60Co BEBIG High Dose Rate for Brachytherapy.
Campos LT; de Almeida CE
PLoS One; 2015; 10(9):e0139032. PubMed ID: 26418559
[TBL] [Abstract][Full Text] [Related]
18. Dosimetry of the 198Au source used in interstitial brachytherapy.
Dauffy LS; Braby LA; Berner BM
Med Phys; 2005 Jun; 32(6):1579-88. PubMed ID: 16013717
[TBL] [Abstract][Full Text] [Related]
19. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
Selvam TP; Sahoo S; Vishwakarma RS
Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
[TBL] [Abstract][Full Text] [Related]
20. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
